The function of vitamin D receptor in vitamin D action

Journal of Biochemistry

Volumn 127, Issue 5, 2000, Pages 717-722

  Kato, Shigeaki ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Nuclear receptor; Transcription factor; VDR KO mice; Vitamin D; Vitamin D 1 hydroxylase

Indexed keywords

TRANSCRIPTION FACTOR; VITAMIN D; VITAMIN D RECEPTOR;

ANIMAL CELL; CALCIUM HOMEOSTASIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME REGULATION; GENE TARGETING; KNOCKOUT MOUSE; NONHUMAN; REVIEW; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0034082854     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jbchem.a022662     Document Type: Review

References (45)

1. Bouillon, R., Okamura, W.H., and Norman, A.W. (1995) Structure-function relationships in the vitamin D endocrine system. Endocr. Rev. 16, 200-257
2. Walters, M.R. (1992) Newly identified actions of the vitamin D endocrine system. Endocr. Rev. 13, 719-764
3. Hughes, M.R., Malloy, P.J., Kieback, D.G., Kesterson, R.A., Pike, J.W., Feldman, D., and O'Malley, B.W. (1988) Point mutations in the human vitamin D receptor associated with hypocalcemic rickets. Science 242, 1702-1705
4. The HYP Consortoim (1995) A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypocalcemic rickets. Nat. Genet. 11, 130-136
5. Kitanaka, S., Takeyama, K., Murayama, A., Sato, T., Okumura, K., Nogami, M., Hasegawa, Y., Niimi, H., Yanagisawa, J., Tanaka, T., and Kato, S. (1998) Inactivating mutations in the human 25-hydroxyvitamin D3 1a-hydroxylase gene in patients with pseudovitamin D-deficient rickets. N. Engl. J. Med. 338, 653-661
6. Kato, S., Yanagisawa, J., Murayama, A., Kitanaka, S., and Takeyama, K. (1998) The importance of 25-hydroxyvitamin D3 1a-hydroxylase gene in vitamin D-dependent rickets. Curr. Opi. Nephrol. Hypertention 7, 377-383
7. Mangelsdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P. et al. (1995) The nuclear receptor superfamily: the second decade. Cell 83, 835-839
8. Norman, A.W., Roth, J., and Orchi, L. (1982) The vitamin D endocrine system:steroid metabolism, hormone receptors, and biological response (calcium binding proteins). Endocr. Rev. 3, 331-366
9. DeLuca, H.F. (1986) The metabolism and functions of vitamin D. Adv. Exp. Med. Biol. 196, 361-375
10. Haussler, M.R., Whitfield, G.K., Haussler, C.A., Hsieh, J.C., Thompson, P.D., Selznick, S.H., Dominguez, C.E., and Jurutka, P.W. (1998) The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J. Bone Miner. Res. 13, 325-349
11. Darwish, H. and DeLuca, H.F. (1993) Vitamin D-regulated gene expression. Crit. Rev. Eukaryotic Gene Express. 3, 89-116
12. Ebihara, K., Masuhiro, Y., Kitamoto, T., Suzawa, M., Uematsu, Y., Yoshizawa, T., Ono, T., Harada, H., Matsuda, K., Hasegawa, T., Masushige, S., and Kato, S. (1996) Intron retention generates a novel isoform of the murine vitamin D receptor that acts in a dominant negative way on the vitamin D signaling pathway. Mol. Cell. Biol. 16, 3393-3400
13. Freedman, L.P. (1999) Increasing the complexity of coactivation in nuclear receptor signalin. Cell 97, 5-8
14. Rachez, C. et al. (1999) Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398, 824-828
15. Yanagisawa, J., Yanagi, Y., Masuhiro, Y., Suzawa, M., Toriyabe, T., Kashiwagi, K., Watanabe, M., Kawabata, M., Miyazono, K., and Kato, S. (1999) Convergence of TGFbeta and vitamin D signaling pathways on SMAD proteins acting as common transcriptional co-activators. Science 283, 1317-1321
16. Takeyama, K., Masuhiro, Y., Fuse, H., Endoh, H., Murayama, A., Kitanaka, S., Suzazawa, M., Yanagisawa, J., and Kato, S. (1999) Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog Mol. Cell. Biol. 19, 1049-1055
17. Chen, H., Lin, R.J., Schiltz, R.L. et al. (1997) Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/ p300. Cell 90, 569-580
18. Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, C., Heyman, A., Rose, W., Glass, K., and Rosenfeld, G. (1996) A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403-414
19. Rachez, C., Lemon, D., Suldan, Z., Bromleigh, V., Gamble, M., Naar, M., Erdjument, H., Tempst, P., and Freedman, P. (1999) Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398, 824-828
20. Yuan, C.X., Ito, M., Fondell, J.D., Fu, Z., and Roeder, R.G. (1998) TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts direct 1y with nuclear receptor in a ligand-depent fashion. Proc. Natl. Acad. Sci. USA 95, 7939-7944
21. Horlein, A.J. et al. (1995) Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor corepressor. Nature 377, 397-404
22. Nagy, L., Kao, H.Y., Chakravarti, D., Lin, R.J., Hassig, C.A., Ayer, D.E., Schreiber, S.L., and Evans, R.M. (1997) Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89, 373-380
23. Malloy, P.J., Hochberg, Z., Tiosano, D., Pike, J.W., Hughes, M.R., and Feldman, D. (1990) The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families. J. Clin. Invest. 86, 2071-2079
24. Yoshizawa, T., Handa, Y., Uemasu, Y., Takeda, S., Sekine, K., Yoshihara, Y., Kawakami, T., Arioka, K., Sato, H., Uchiyama, Y., Masushige, S., Fukamizu, A., Matsumoto, T., and Kato, A. (1997) Impaired bone formation and uterine hypoplasia with growth retardation after weaning in mice lacking the vitamin D receptor. Nat. Genet. 16, 391-396
25. Kastner, P., Mark, M., and Chambon, P. (1995) Nonsteroidy nuclear receptors: what are genetic studies telling us about their role in real life? Cell 83, 859-869
26. Li, Y.C., Pirro, A.E., Amling, M., Delling, G., Baron, R., Bronson, R., and Demay M.B. (1997) Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. USA 94, 9831-9835
27. Suda, T. and Takahashi, N. (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20, 345-357
28. Takahashi, N., Udagawa, N., Akatsu, T. et al. (1991) Deficiency of osteoclasts in osteopetrotic mice is due to a defect in the local microenvironment provided by osteoblastic cells. Endocrinology 128, 1792-1796
29. Takeyama, K., Kitanaka, S., Sato, T., Kobori, M., Yanagisawa, J., and Kato, S. (1997) 25-Hydroxyvitamin D3 1a-hydroxylase and vitamin D synthesis. Science 277, 1827-1830
30. Fu, G.K., Lin, D., Zhang, M.Y.H., Bikle, D.D., Shackleton, C.H.L., Miller, W.L., Portale, A.A. (1997) Cloning of human 25-hydroxyvitamin D-1α-hydroxylase a mutations causing vitamin D-dependent rickets type 1. Mol. Endocrinol. 11, 1961-1970
31. Monkawa, T., Yoshida, T., Wakino, S., Shinki, T., Anazawa, H., DeLuca, F.F., Suda, T., Hayashi, M., and Saruta, T. (1997) Molecular cloning of cDNA and genomic DNA for human 25-hydroxyvitamin D3 1α-hydroxylase. Biochem. Biophys. Res. Commun. 239, 527-533
32. Scriver, C.R., Reade, T.M., DeLuca, H.F., and Hamstra, A.J. (1978) Serum1,25-dihydroxyvitamin D levels in normal subjects and patients with hereditary rickets or bone disease. N. Engl. J. Med. 299, 976-979
33. Labuda, M., Morgan, K., and Glorieux, F.H. (1990) Mapping autosomal recessive vitamin D dependency type 1 to chromosomal 12q14 by linkage abalysis. Am. J. Hum. Genet. 47, 28-36
34. Kitanaka, S., Murayama, A., Sakaki, T., Inoue, K., Seino, Y., Fukumoto, S., Shima, M., Yukizane, S., Takayanagi, M., Niimi, H.,Takeyama, K., and Kato, S. (1999) No enzyme activity of 25-hydroxyvitamin D3 1a-hydroxylase geneproduct in pseudovitamin D-deficiency rickets with mild clinical manifestation. J. Clin. Endocrinol. Metab. 84, 4111-4117
35. Portale, A.A., Halloran, B.P., Morris, R.C., Jr. (1989) Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men. J. Clin. Invest. 83, 1494-1499
36. Sawada, N., Sakaki, T., Kitanaka, S., Takeyama, K., Kato, S., and Inouye, K. (1999) Enzymatic properties of human 25-hydroxyvitamin D3 1a-hydroxylase coexpression with adrenodoxin and NADPH-adrenodoxin reductase in Escherichia coli. Eur. J. Biochem. 265, 950-956
37. Sakaki, T., Sawada, N., Takeyama, K., Kato, S., and Inouye, K. (1999) Enzymatic properties of mouse 25-hydroxyvitamin D3 1a-hydroxylase expressed in Escherichia coli. Eur. J. Biochem. 259, 731-738
38. Kawashima, H., Torikai, S., and Kurokawa, K. (1981) Localization of 25-hydroxyvitamin D3-1a-hydroxylase along the rat nephron. Proc. Natl. Acad. Sci. USA 78, 1199-1203
39. 3 in intact animals. Endocrinology 140, 2224-2231
40. Henry, H.L. (1979) Regulation of the hydroxylation of 25-hydroxyvitamin D3-1α-hydroxylase in vivo and in primary cultures of chick kidney cells. J. Biol. Chem. 254, 2722-2729
41. Henry, H.L. (1985) Parathyroid hormone modulation of 25-hydroxyvitamin D3 metabolism by cultured chick kidney cells is mimicked and enhanced by forskolin. Endocrinology 116, 503-507
42. Brenza, H., Kimmel-Jehan, C., Jehan, F., Shinki, T., Wakino, S., Anazawa, M., Suda, T., and DeLuca H.F. (1998) Parathyroid hormone activation of the rat 25-hydroxyvitamin D3-1a-hydroxylase gene promoter. Proc. Natl. Acad. Sci. USA 95, 1387-1391
43. 3. Biochem. Biophys. Res. Commun. 249, 121-126
44. Demay, M.B., Kiernan, M.S., DeLuca, H.F., and Kronenberg, H.M. (1992) Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D receptor and mediate transcriptional response to 1,25-dihydroxyvitamin D. Proc. Natl. Acad. Sci. USA 89, 8097-8101
45. Mackey, S.L., Heymont, J.L., Kronenberg, H.M., and Demay, M.B. (1996) Vitamin D receptor binding to the negative human prathyroid hormone vitamin D response element does not require the retinoid X receptor. Mol. Endocrinol. 10, 298-305